NASDAQ

Eloxx Pharmaceuticals, Inc. (ELOX)

♥ 535 Thanks from members

Live price chart, market sentiment, and community perspectives for Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Robert S. AmesFounder: Orphazyme managementLeadership: Sumit Aggarwal (President and CEO)Leadership: Neil Bell (CFO)Holder: Polaris PartnersHolder: Aberdeen Asset ManagementHolder: RA Capital ManagementHolder: BlackRock, Inc.Holder: Vanguard GroupELX-02Ribosome-targeting small moleculesNonsense mutation genetic therapies#ELOX#Eloxx Pharmaceuticals#NASDAQ ELOX#Biotech Stock#Rare Disease Therapeutics